Ahmed glaucoma valve implantation with and without subconjunctival bevacizumab in refractory glaucoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology
Link
https://link.springer.com/content/pdf/10.1007/s10792-021-01691-7.pdf
Reference31 articles.
1. Tailor R, Kinsella MT, Clarke JC (2018) Long-term outcome of intravitreal bevacizumab followed by ahmed valve implantation in the management of neovascular glaucoma. Semin ophthalmol 33:606–612
2. Assaad MH, Baerveldt G, Rockwood EJ (1999) Glaucoma drainage devices: pros and cons. Curr Opin Ophthalmol 10:147–153
3. Coleman AL, Hill R, Wilson MR et al (1995) Initial clinical experience with the Ahmed Glaucoma valve implant. Am J Ophthalmol 120:23–31
4. Eid TE, Katz LJ, Spaeth GL et al (1997) Tube-shunt surgery versus neodymium:YAG cyclophotocoagulation in the management of neovascular glaucoma. Ophthalmology 104:1692–1700
5. Katz LJ, Spaeth GL (1987) Surgical management of the secondary glaucomas: part I. Ophthalmic Surg 18:826–834
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Long-term results of Ahmed glaucoma valve implantation with/without intravitreal anti-VEGF injection in neovascular glaucoma patients;Journal Français d'Ophtalmologie;2024-10
2. The efficacy and safety of anti-vascular endothelial growth factor combined with Ahmed glaucoma valve implantation in the treatment of neovascular glaucoma: a systematic review and meta-analysis;Frontiers in Medicine;2024-07-31
3. The efficacy of adjunctive mitomycin C and/or anti-VEGF agents on glaucoma tube shunt drainage device surgeries: a systematic review;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-04-24
4. Does Bevacizumab Improve Outcomes After Ahmed Glaucoma Valve Implantation for Refractory Glaucoma?: A Meta-Analysis;Journal of Glaucoma;2024-01-09
5. Anti-vascular endothelial growth factor for neovascular glaucoma;Cochrane Database of Systematic Reviews;2023-04-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3